Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells

Biochemical Pharmacology

Volumn 67, Issue 1, 2004, Pages 167-174

  Mak, Nai Ki ^a   Leung, Chung Yee ^a   Wei, Xiao Yi ^a,b   Shen, Xiao Ling ^a,c   Wong, Ricky Ngok Shun ^a   Leung, Kwok Nam ^d   Fung, Ming Chiu ^d  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b SOUTH CHINA INSTITUTE OF BOTANY   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

IkB; Indirubin; Indirubin 3 oxime; Influenza; p38 MAP kinase; RANTES

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDIRUBIN; INDIRUBIN 3' OXIME; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; RANTES; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLUENZA; INFLUENZA VIRUS; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VIRUS STRAIN;

EID: 0344255572     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.08.020     Document Type: Article

References (27)

1. Julkunen I., Sareneva T., Pirhonen J., Ronni T., Melen K., Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 12:2001;171-180.
2. Bonville C.A., Rosenberg H.F., Domachowske J.B. Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr. Allergy Immunol. 10:1999;39-44.
3. Becker S., Reed W., Henderson F.W., Noah T.L. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am. J. Physiol. 272:1997;L512-L520.
4. Kunikata T., Tatefuji T., Aga H., Iwaki K., Ikeda M., Kurimoto M. Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur. J. Pharmacol. 410:2000;93-100.
5. Matsukura S., Kokubu F., Kubo H., Tomita T., Tokunaga H., Kadokura M., Yamamoto T., Kuroiwa Y., Ohno T., Suzaki H., Adachi M. Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am. J. Respir. Cell Mol. Biol. 18:1998;255-264.
6. Asai Y., Hashimoto S., Kujime K., Gon Y., Mizumura K., Shimizu K., Horie T. Amantadine inhibits RANTES production by influenzavirus-infected human bronchial epithelial cells. Br. J. Pharmacol. 132:2001;918-924.
7. Hoessel R., Leclerc S., Endicott J.A., Nobel M.E., Lawrie A., Tunnah P., Leost M., Damiens E., Marie D., Marko D., Niederberger E., Tang W., Eisenbrand G., Meijer L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1:1999;60-67.
8. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
9. Matsukura S., Kokubu F., Noda H., Tokunaga H., Adachi M. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J. Allergy Clin. Immunol. 98:1996;1080-1087.
10. Julkunen I., Melen K., Nyqvist M., Pirhonen J., Sareneva T., Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine. 19(Suppl. 1):2000;S32-S37.
11. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet. Microbiol. 74:2000;109-116.
12. Lillard J.W. Jr., Boyaka P.N., Taub D.D., McGhee J.R. RANTES potentiates antigen-specific mucosal immune responses. J. Immunol. 166:2001;162-169.
13. Sprenger H., Meyer R.G., Kaufmann A., Bussfeld D., Rischkowsky E., Gemsa D. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J. Exp. Med. 184:1996;1191-1196.
14. Adachi M., Matsukura S., Tokunaga H., Kokubu F. Expression of cytokines on human bronchial epithelial cells induced by influenza virus A. Int. Arch. Allergy Immunol. 113:1997;307-311.
15. Castells E., George V.G., Hierholzer J.C. NCI-H292 as an alternative cell line for the isolation and propagation of the human paramyxoviruses. Arch. Virol. 115:1990;277-288.
16. Hierholzer J.C., Castells E., Banks G.G., Bryan J.A., McEwen C.T. Sensitivity of NCI-H292 human lung mucoepidermoid cells for respiratory and other human viruses. J. Clin. Microbiol. 31:1993;1504-1510.
17. Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells. 12:1994;53-63.
18. Matikainen S., Pirhonen J., Miettinen M., Lehtonen A., Govenius-Vintola C., Sareneva T., Julkunen I. Influenza A and Sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages [record supplied by publisher]. Virology. 276:2000;138-147.
19. Flory E., Kunz M., Scheller C., Jassoy C., Stauber R., Rapp U.R., Ludwig S. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J. Biol. Chem. 275:2000;8307-8314.
20. Thomas L.H., Friedland J.S., Sharland M., Becker S. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J. Immunol. 161:1998;1007-1016.
21. Marko D., Schatzle S., Friedel A., Genzlinger A., Zankl H., Meijer L., Eisenbrand G. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br. J. Cancer. 84:2001;283-289.
22. Leclerc S., Garnier M., Hoessel R., Marko D., Bibb J.A., Snyder G.L., Greengard P., Biernat J., Wu Y.Z., Mandelkow E.M., Eisenbrand G., Meijer L. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 276:2001;251-260.
23. 2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J. Immunol. 164:2000;3222-3228.
24. Gern J.E., French D.A., Grindle K.A., Brockman-Schneider R.A., Konno S., Busse W.W. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 28:2003;731-737.
25. Cui C.H., Adachi T., Oyamada H., Kamada Y., Kuwasaki T., Yamada Y., Saito N., Kayaba H., Chihara J. The role of mitogen-activated protein kinases in eotaxin-induced cytokine production from bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 27:2002;329-335.
26. Holtmann H., Winzen R., Holland P., Eickemeier S., Hoffmann E., Wallach D., Malinin N.L., Cooper J.A., Resch K., Kracht M. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol. Cell. Biol. 19:1999;6742-6753.
27. Escotte S., Tabary O., Dusser D., Majer-Teboul C., Puchelle E., Jacquot J. Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway. Eur. Respir. J. 21:2003;574-581.